Evidence map›Paper›PMID 35222800›Full record

ArticleOxidative medicine and cellular longevity2022

Effects of

Francesca Maria Orlandella, Peppino Mirabelli, Anna Elisa De Stefano, Paola Lucia Chiara Iervolino, Neila Luciano, Stefania D'Angelo, Giuliana Salvatore

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. The mechanism and application ofFrontiers in endocrinology · 2025
    Review
  7. Article
  8. Article
  9. Vernodalin Triggers ROS-Mediated Apoptosis in TPC-1 Human PapillaryThyroid Cancer CellsCombinatorial chemistry & high throughput screening · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Francesca Maria OrlandellaIRCCS SYNLAB SDN, Naples, Italy.ORCID https://orcid.org/0000-0002-4537-3113
Peppino MirabelliIRCCS SYNLAB SDN, Naples, Italy.ORCID https://orcid.org/0000-0002-2183-7577
Anna Elisa De StefanoDipartimento di Scienze Motorie e del Benessere, Università di Napoli Parthenope, Naples, Italy.
Paola Lucia Chiara IervolinoCEINGE-Biotecnologie Avanzate S.c.a.r.l., Naples, Italy.
Neila LucianoDipartimento di Scienze Motorie e del Benessere, Università di Napoli Parthenope, Naples, Italy.ORCID https://orcid.org/0000-0002-5239-2910
Stefania D'AngeloDipartimento di Scienze Motorie e del Benessere, Università di Napoli Parthenope, Naples, Italy.ORCID https://orcid.org/0000-0001-7585-5052
Giuliana SalvatoreIRCCS SYNLAB SDN, Naples, Italy.ORCID https://orcid.org/0000-0001-5741-5598
Parthenope University of Naples · ITCeinge Biotecnologie Avanzate (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among natural macromolecules, the polyphenol extract from

Indexed as

Antineoplastic AgentsAntioxidantsCell CycleCell Line, TumorCell SurvivalFruitGene Expression Regulation, NeoplasticHumansMalusMicroRNAsOxidative StressPhosphorylationPlant ExtractsPolyphenolsRetinoblastoma ProteinThyroid NeoplasmsAntineoplastic AgentsAntioxidantsMicroRNAsPlant ExtractsPolyphenolsRetinoblastoma Protein

Identifiers

PMID35222800
PMCPMC8872649
OpenAlexW4213184358

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.